Table 1 Results
From: Abstracts from the 8th Drug Hypersensitivity Meeting (DHM)
Short-time group (≤ 21 days) n = 48 | Long-time group (> 21 days) n = 27 |
|---|---|
Amoxicillin: n = 10 | Carbamazepine: n = 8 |
Iodinated contrast media : n = 7 | Salazopyrin: n = 2 |
Lamotrigine: n = 4 | Lamotrigine: n = 6 |
Ceftriaxone: n = 3 | Allopurinol: n = 2 |
Olanzapine: n = 2 | Rifampicine: n = 1 |
Terbinafine: n = 2 | Adiazine: n = 1 |
Isoniazide: n = 2 | Biperidene: n = 1 |
Atovaquone: n = 2 | Vancomycin: n = 1 |
Bactrim: n = 1 | Bactrim: n = 1 |
Tazocillin: n = 1 | Tazocillin: n = 1 |
Fluindione: n = 1 | Fluindione: n = 1 |
Cefuroxime: n = 1 | Raltegravir : n = 1 |
Cefpodoxime: n = 1 | Fluconazole: n = 1 |
Ceftazidime: n = 1 |  |
Meronem: n = 1 |  |
Dalacine: n = 1 |  |
Rovamycine: n = 1 |  |
Atazanavir : n = 1 |  |
Etravirine: n = 1 |  |
Emtricitabine/tenofovir: n = 1 |  |
Abacavir: n = 1 |  |
Valaciclovir: n = 1 |  |
Miconazole: n = 1 |  |
Anafranil: n = 1 |  |